Please login to the form below
The Prime Medical Group
This page shows the latest The Prime Medical Group news and features for those working in and with pharma, biotech and healthcare.
The Prime Medical Group rebrands as Prime Global
Moves to highlight healthcare communications group’s international status. Medical communications specialist The Prime Medical Group has undergone a rebrand, changing its name to Prime Global. ... Graeme Peterson, group chairman and chief executive
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
The Prime Medical Group strengthens leadership team
Karen Turner and Gauri Saal join the comms agency. Global communications agency The Prime Medical Group has appointed Karen Turner as vice president of client services and Gauri Saal as principal ... She joins The Prime Medical Group from Watermeadow
-
Creative directors join The Prime Medical Group’s UK offices
Adam Moriarty and Craig Armstrong join London and Cheshire teams. Medical education and communications firm The Prime Medical Group has appointed two new creative directors to its UK offices. ... Meanwhile, Craig Armstrong (pictured above) joins The
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
Prime Global
Prime Global- The medical communications people. Prime Global is a group of six full-service medical communications agencies and specialist consultancies. ... Prime Global.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Creabilis names Catherine Moukheibir as chairman of the board
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- MIT researchers develop AI model to detect future lung cancer risk
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
